Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 01, 2024, titled "Aurobindo Pharma receives USFDA approval for Fingolimod Capsules, 0.5 mg".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 01, 2024, titled "Aurobindo Pharma receives USFDA approval for Fingolimod Capsules, 0.5 mg".